Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-06-08 to 2023-06-30
Current total value of award: $1150.71
Description: 4561201716!OMIDRIA 1-0.3% VIAL 4ML